Marra, Alberto M.
Halank, Michael
Benjamin, Nicola
Bossone, Eduardo
Cittadini, Antonio
Eichstaedt, Christina A.
Egenlauf, Benjamin
Harutyunova, Satenik
Fischer, Christine
Gall, Henning
Ghofrani, Hossein Ardeschir
Hoeper, Marius M.
Lange, Tobias J.
Olsson, Karen M.
Klose, Hans
Grünig, Ekkehard
Funding for this research was provided by:
Bayer HealthCare (not applicable)
Article History
Received: 27 September 2018
Accepted: 29 November 2018
First Online: 19 December 2018
Ethics approval and consent to participate
: All riociguat studies were approved by the ethics committees of the respective centers. All data were double-pseudonymized. The ethics committee of the medical faculty, University of Heidelberg had no objection against the retrospective analysis of echocardiographic data within this study (S668–2015).
: Not applicable
: AMM: received grants from Italian Helthcare Ministry, grant for young researchers “Ricerca finalizzata 2016 per giovani ricercatori” n. GR-2016-02364727, personal lecture fee from Bayer Healthcare.MH: Fees for consulting and/or lectures and conference expenses from Actelion, Bayer, Gilead, GSK, Merck, Novartis, OMT and Pfizer.NB: speaker honoraria from Actelion pharmaceuticals.EB: nothing to disclose.AC: nothing to disclose.CAE: nothing to disclose.BE: nothing to disclose.CF: nothing to disclose.HG: has received support and/or honoraria from Actelion, AstraZeneca, Bayer, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Cilag, Lilly, Merck Sharp Dohme, Novartis, Pfizer, and United Therapeutics/OMT.HAG: received fees for lectures and/or consulting from Actelion, Bayer, Gilead, GSK, MSD, Novartis, Pfizer and United Therapeutics.MMH: Fees for consulting and/or lectures from Actelion, Bayer, Gilead, GSK, Merck and Pfizer.TJL: received fees for lectures and/or consulting and/or research support to institution from Actelion, AOP orphan/OMT, Bayer, GSK, Pfizer, United Therapeutics.KMO: speaker and consultancy fees from Actelion pharmaceuticals.HK: received fees for talks and/or consulting work from Actelion, Bayer, MSD, GSK and Pfizer; research funding from GSK, Actelion and Bayer.EG: received fees for talks and/or consulting work from Actelion, Bayer, GSK, MSD, Novartis, Pfizer and United Therapeutics. Research funding from GSK, Actelion and Bayer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.